Cure CMT4J

Jocelyn Duff
Published Online: Thursday, Oct 20, 2016
At the 2016 NORD Breakthrough Summit in Arlington, Virginia, we spoke with Jocelyn Duff, Executive Director of the Cure CMT4J Foundation. 

For more information, go to http://curecmt4j.org/

Latest Articles
Positive initial results from a Phase 1A clinical trial evaluating setmelanotide (RM-492) for the treatment of rare genetic disorders of obesity were reported.
He’s a patient, an educator, and an advocate. Huntington's Disease patient and Bellingham researcher Jeff Carroll is a triple threat.
Dr Gavin Rumbaugh, PhD of Scripps Florida Research Institute was awarded an NIMH-funded grant for the therapeutic development of Syngap1.
Cooper sits down with RDR to talk about A4250, why it’s so important to children with PFIC, and just how Albireo prioritizes treatment for rare diseases.
$vacMongoViewPlus$ $vAR$